ctDNA Clearance Predicts Relapse Risk in Urothelial Cancer ctDNA Clearance Predicts Relapse Risk in Urothelial Cancer

New research shows that ctDNA clearance following neoadjuvant treatment of muscle-invasive urothelial cancer can help predict response to therapy and the risk for relapse.MDedge News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news